Nizamudin, M., Kumar, M.P., Gautham, A., Sriram, D.K. and George, M. 2020. Roflumilast: First approved oral selective PDE4 inhibitor for the treatment of COPD. International Journal of Health and Clinical Research. 3, 5 (Sep. 2020), 85–89.